杂志简称：drug aging
中文译名：《药物与衰老》
收录属性：scie（2024版）, 目次收录（维普）,英文期刊,
自引率：5.20%
投稿方向：医学、geriatrics & gerontology 老年医学、pharmacology & pharmacy 药学
SCI/E期刊基本信息
出版周期：月刊 地区：新西兰
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN1170-229X；EISSN1179-1969
杂志语言：英语
出版国家：新西兰
杂志官网 联系方式
出版地址：ADIS INT LTD,41 CENTORIAN DR,PRIVATE BAG 65901,MAIRANGI BAY,AUCKLAND,NEW ZEALAND,1311
杂志邮箱：
投稿网址：https://www.editorialmanager.com/draa/
杂志官方网址：https://www.springer.com/journal/40266
出版商网址：http://www.adisonline.info
杂志投稿要求
期刊相关咨询邮箱【杂志社官方网站信息】
Contact the journal
Submission-related enquiries
Queries about submission issues, peer review process, or the status of your manuscript should be sent to Kiruthika Gunaselvam (kiruthika.gunaselvam@springernature.com).
Publication-related enquiries
Queries about accepted manuscripts in production or post-publication corrections should be sent to Pressila Thiagaraj (Pressila.Thiagaraj@springernature.com).
Other editorial enquiries
Any other queries about the journal or presubmission enquiries should be sent to David Williamson (David.Williamson@springer.com).
投稿须知【杂志社官方网站信息】
Submission guidelines
Instructions for Authors
Please read these instructions in conjunction with the "Additional Information for Authors" document. This document, together with other useful submission documentation, can be found by following the "Important Information for Authors" link:
Important Information for Authors
Types of Papers
Please note:
The word counts given below do not include the abstract, references, figure legends or table captions.
Review Article – Word count up to 6000. Provides an authoritative, balanced, comprehensive, fully referenced and critical review of the literature.
Current Opinion – Word count 1500 to 3000. Places an area in perspective given that it is of current international interest and a consensus has not yet been reached; therefore, the arguments presented may be controversial, but at the same time must be balanced and rational.
Leading Article – Word count up to 3000. Provides a short, balanced overview of the current status of an emerging area.
Therapy in Practice – Word count up to 4000. Provides a succinct, clinically orientated guide to the optimum management of the disease/disorder/situation which highlights practical, clinically relevant considerations and recommendations, rather than those of theoretical or academic interest. May include management 'flow charts' or treatment protocols where appropriate.
Systematic Review – Word count up to 10,000. Collates all empirical evidence that fits pre-specified eligibility criteria to answer a specific research question. It uses explicit, systematic methods that are selected with a view to minimizing bias, thus providing reliable findings from which conclusions can be drawn and decisions made. Please follow the reporting guidelines of PRISMA.
Original research – Drugs & Aging will consider studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials (particularly well-designed, randomised studies), meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies. Such papers should be submitted as Original Research Articles (word count up to 6000).
Letter to the Editor – Word count up to 1000. Comment on an article published recently in the journal; a response to the comments would normally be sought from the authors of the original article and published in the same issue, where possible.
Editorial/Commentary – Word count up to 1500. A brief opinion piece on a current topic of high interest.
Editorial Procedure
Internal Review by Editorial Staff: The journal editor will perform an initial appraisal of each manuscript. If your paper has been peer reviewed by another journal as part of a prior submission, the journal editor will also assess any previous editorial/referee comments and how these have been dealt with as part of the appraisal process. If your manuscript is considered unsuitable for the journal to which it has been submitted, it may be assessed for suitability for publication in other Adis journals by appropriate editors. However, it will not be progressed to external peer review for an alternative journal without your permission.
External Peer Review: Peer reviewer identities are kept confidential, but author identities are known to the reviewers. Peer reviewers are asked to disclose potential conflicts of interests that may affect their ability to provide an unbiased review of an article. The majority of manuscripts will require some degree of revision following peer review before they can be accepted for publication. The final decision on acceptability for publication lies with the journal editor.
Copy Editing: All accepted manuscripts are copy edited. This process addresses general publishing considerations, such as layout of tables and figures, housestyle and clarity of expression. Authors will receive proofs following editing for their approval and sign off. It should be noted that the responsibility for checking the technical accuracy and consistency of data within the article rests with the authors.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Please note:
Please note that, for some articles (particularly, systematic reviews and original research articles), 250 words may not be sufficient to provide all necessary information in the abstract. Therefore, the abstract length can be increased from the 250-word limit (to up to 450 words) if the topic dictates, and to allow full compliance with the relevant reporting guidelines.
Text
Text Formatting
Manuscripts should be submitted in Word.
Use a normal, plain font (e.g., 10-point Times Roman) for text.
Use italics for emphasis.
Use the automatic page numbering function to number the pages.
Do not use field functions.
Use tab stops or other commands for indents, not the space bar.
Use the table function, not spreadsheets, to make tables.
Use the equation editor or MathType for equations.
Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Headings
Please use the decimal system of headings with no more than three levels.
Abbreviations
Abbreviations should be defined at first mention and used consistently thereafter.
Footnotes
Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
Always use footnotes instead of endnotes.
Acknowledgments
Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.